
    
      Design: A prospective, randomized controlled trial over 5 months. Patients: Newborns admitted
      within 6 hours after birth with gestation >32 weeks, Apgar score of <6 at 5 minutes, features
      suggestive of neonatal encephalopathy.

      Intervention: After randomization, Group A newborns received oral vitamin C 250 mg once a day
      within a 24-hour interval along with a single dose of vitamin E 200 IU. Group B newborns
      received no intervention.

      Outcome measures: Severity and progression of birth asphyxia, duration of hospitalization and
      mechanical ventilation, mortality, and neurodevelopmental outcome.
    
  